Dyne Therapeutics, Inc. (DYN)
19.59
+1.15
(+6.24%)
USD |
NASDAQ |
Dec 10, 15:29
Dyne Therapeutics Market Cap: 2.798B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Avidity Biosciences, Inc. | 10.76B |
| CEL-SCI Corp. | 19.82M |
| AIM ImmunoTech, Inc. | 1.116M |
| IGC Pharma, Inc. | 32.17M |
| NovaBay Pharmaceuticals, Inc. | 302.43M |
Market Cap Related Metrics
| PEG Ratio | -1.943 |
| Price to Book Value | 4.045 |
| Price | 19.59 |
| Earnings Yield | -18.68% |
| PEGY Ratio | -1.943 |